Early Access — free while we kick the tires
EdgarHawk

KWON YOUNG

Director

Director
1 filing analyzed · 1 company · Latest 2024-08-27

Companies

Company Buys Sells Direction
ADMA BIOLOGICS, INC. ADMA 0 1 Net selling

Activity

August 2024
2024-08-27 ADMA BIOLOGICS, INC. ADMA
high
Sell
60,000 shares
$1,095,600
Significance 6/10

Director Kwon Young sold 60,000 shares of ADMA at $18.26 on 2024-08-23, reducing stake by 19.9% to 241,441 shares.

Director Kwon Young executed a substantial sale of 60,000 shares at $18.26, representing a 19.9% reduction in holdings and totaling $1,095,600.00. The transaction occurred near the stock's 52-week high of $18.40, where ADMA has rallied 31.8% over the preceding 30 days and 84.6% over 90 days. However, the company's fundamentals present a mixed picture: while revenue reached $107,191,000.00 with net income of $32,062,000.00 in the latest quarter and annual revenue growth accelerated to 67.6%, the full fiscal year remains unprofitable with a P/E of 115.67 reflecting elevated valuation expectations. This substantial directed sale during a sharp price recovery warrants investor attention regarding insider perspective on current valuations relative to operational profitability.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access